National Academies Press: OpenBook

Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident (2004)

Chapter: Appendix A: Public Law 107-188, Public Health Security and Bioterrorism Preparedness Response Act of 2002

« Previous: References
Suggested Citation:"Appendix A: Public Law 107-188, Public Health Security and Bioterrorism Preparedness Response Act of 2002." National Research Council. 2004. Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. Washington, DC: The National Academies Press. doi: 10.17226/10868.
×

APPENDIX A
PUBLIC LAW 107-188, PUBLIC HEALTH SECURITY AND BIOTERRORISM PREPAREDNESS AND RESPONSE ACT OF 2002, CONFERENCE COMMITTEE (05/21/02)

SEC. 127. POTASSIUM IODIDE.

(a) IN GENERAL.-Through the national stockpile under section 121, the President, subject to subsections (b) and (c), shall make available to State and local governments potassium iodide tablets for stockpiling and for distribution as appropriate to public facilities, such as schools and hospitals, in quantities sufficient to provide adequate protection for the population within 20 miles of a nuclear power plant.

(b) STATE AND LOCAL PLANS.-

(1) IN GENERAL.-Subsection (a) applies with respect to a State or local government, subject to paragraph (2), if the government involved meets the following conditions:

(A) Such government submits to the President a plan for the stockpiling of potassium iodide tablets, and for the distribution and utilization of potassium iodide tablets in the event of a nuclear incident.

Suggested Citation:"Appendix A: Public Law 107-188, Public Health Security and Bioterrorism Preparedness Response Act of 2002." National Research Council. 2004. Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. Washington, DC: The National Academies Press. doi: 10.17226/10868.
×

(B) The plan is accompanied by certifications by such government that the government has not already received sufficient quantities of potassium iodide tablets from the Federal Government.

(2) LOCAL GOVERNMENTS.-Subsection (a) applies with respect to a local government only if, in addition to the conditions described in paragraph (1), the following conditions are met:

(A) The State in which the locality involved is located-

(i) does not have a plan described in paragraph (1)(A); or

(ii) has a plan described in such paragraph, but the plan does not address populations at a distance greater than 10 miles from the nuclear power plant involved.

(B) The local government has petitioned the State to modify the State plan to address such populations, not exceeding 20 miles from such plant, and 60 days have elapsed without the State modifying the State plan to address populations at the full distance sought by the local government through the petition.

(C) The local government has submitted its local plan under paragraph (1)(A) to the State, and the State has approved the plan and certified that the plan is not inconsistent with the State emergency plan.

(c) GUIDELINES.-Not later than one year after the date of the enactment of this Act, the President, in consultation

Suggested Citation:"Appendix A: Public Law 107-188, Public Health Security and Bioterrorism Preparedness Response Act of 2002." National Research Council. 2004. Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. Washington, DC: The National Academies Press. doi: 10.17226/10868.
×

with individuals representing appropriate Federal, State, and local agencies, shall establish guidelines for the stockpiling of potassium iodide tablets, and for the distribution and utilization of potassium iodide tablets in the event of a nuclear incident. Such tablets may not be made available under subsection (a) until such guidelines have been established.

(d) INFORMATION.-The President shall carry out activities to inform State and local governments of the program under this section.

(e) REPORTS.-

(1) PRESIDENT.-Not later than six months after the date on which the guidelines under subsection (c) are issued, the President shall submit to the Congress a report-

(A) on whether potassium iodide tablets have been made available under subsection (a) or other Federal, State, or local programs, and the extent to which State and local governments have established stockpiles of such tablets; and

(B) the measures taken by the President to implement this section.

(2) NATIONAL ACADEMY OF SCIENCES.-

(A) IN GENERAL.-The President shall request the National Academy of Sciences to enter into an agreement with the President under which the Academy conducts a study to determine what is the most effective and safe way to distribute and administer potassium iodide tablets on a mass scale. If the Academy declines to conduct the study, the President shall enter into an agreement

Suggested Citation:"Appendix A: Public Law 107-188, Public Health Security and Bioterrorism Preparedness Response Act of 2002." National Research Council. 2004. Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. Washington, DC: The National Academies Press. doi: 10.17226/10868.
×

with another appropriate public or nonprofit private entity to conduct the study.

(B) REPORT.-The President shall ensure that, not later than six months after the date of the enactment of this Act, the study required in subparagraph (A) is completed and a report describing the findings made in the study is submitted to the Congress.

(f) APPLICABILITY.-Subsections (a) and (d) cease to apply as requirements if the President determines that there is an alternative and more effective prophylaxis or preventive measures for adverse thyroid conditions that may result from the release of radionuclides from nuclear power plants.

Suggested Citation:"Appendix A: Public Law 107-188, Public Health Security and Bioterrorism Preparedness Response Act of 2002." National Research Council. 2004. Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. Washington, DC: The National Academies Press. doi: 10.17226/10868.
×
Page 183
Suggested Citation:"Appendix A: Public Law 107-188, Public Health Security and Bioterrorism Preparedness Response Act of 2002." National Research Council. 2004. Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. Washington, DC: The National Academies Press. doi: 10.17226/10868.
×
Page 184
Suggested Citation:"Appendix A: Public Law 107-188, Public Health Security and Bioterrorism Preparedness Response Act of 2002." National Research Council. 2004. Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. Washington, DC: The National Academies Press. doi: 10.17226/10868.
×
Page 185
Suggested Citation:"Appendix A: Public Law 107-188, Public Health Security and Bioterrorism Preparedness Response Act of 2002." National Research Council. 2004. Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. Washington, DC: The National Academies Press. doi: 10.17226/10868.
×
Page 186
Next: Appendix B: Fission Product Inventories »
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident Get This Book
×
Buy Paperback | $49.00 Buy Ebook | $39.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Radioactive iodines are produced during the operation of nuclear power plants and during the detonation of nuclear weapons. In the event of a radiation incident, radioiodine is one of the contaminants that could be released into the environment. Exposure to radioiodine can lead to radiation injury to the thyroid, including thyroid cancer. Radiation to the thyroid from radioiodine can be limited by taking a nonradioactive iodine (stable iodine) such as potassium iodide. This book assesses strategies for the distribution and administration of potassium iodide (KI) in the event of a nuclear incident. The report says that potassium iodide pills should be available to everyone age 40 or younger—especially children and pregnant and lactating women—living near a nuclear power plant. States and municipalities should decide how to stockpile, distribute, and administer potassium iodide tablets, and federal agencies should keep a backup supply of tablets and be prepared to distribute them to affected areas.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!